Novavax (NVAX) Return on Capital Employed (2011 - 2026)

Novavax's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 10.18% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 5114.0% year-over-year to 10.18% in Q1 2026; TTM through Mar 2026 was 10.18%, a 5114.0% decrease from a year earlier, with the FY2025 full-year figure at 49.84%, up 9730.0% from the prior year.
• Return on Capital Employed fell to 10.18% in Q1 2026 per NVAX's latest filing, from 63.04% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 6421.91% in Q1 2023 and bottomed at 3566.59% in Q2 2023.
• The 5-year median for Return on Capital Employed is 51.64% (2024), against an average of 89.17%.
• Across the five-year window, Return on Capital Employed jumped 670712 bps in 2023 and sank 647359 bps in 2024, its largest moves.
• Year by year, Return on Capital Employed stood at 327.47% in 2022, then tumbled by 288 bps to 614.53% in 2023, then surged by 92 bps to 51.64% in 2024, then surged by 222 bps to 63.04% in 2025, then sank by 116 bps to 10.18% in 2026.
• Per Business Quant, the three latest NVAX Return on Capital Employed figures stand at 10.18% (Q1 2026), 63.04% (Q4 2025), and 37.12% (Q3 2025).